Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2011 | 09-2011 | |
Operating Expenses | 0 | 1,274 |
Operating Income | N/A | -1,274 |
Interest Expense | 0 | 1 |
Other Income | 0 | 2 |
Pre-tax Income | 0 | -1,273 |
Net Income Continuous | N/A | -1,273 |
Net Income | $N/A | $-1,273 |
EPS Basic Total Ops | N/A | -19.80 |
EPS Basic Continuous Ops | N/A | -20.35 |
EPS Diluted Total Ops | N/A | -19.80 |
EPS Diluted Continuous Ops | N/A | -20.35 |
EBITDA(a) | $N/A | $-1,274 |